Researchers of the IDIBELL and the Hospital Vall d'Hebron have studied a family affected by both type 1 neurofibromatosis and early breast cancer and they have detected mutations in NF1 and BRCA1 genes responsible for the two diseases, respectively.
The IDIBELL researcher Gabriel Capellá has been appointed new Head of Research and Innovation for Health of the Health Department of the Generalitat de Catalunya, replacing Marta Aymerich.